Showing results (31-40 of 300) with videos related to
Sort By:
Pageof 30
Leukemia|October 23, 2009
JAK2 germline genetic variation affects disease susceptibility in primary myelofibrosis regardless of V617F mutational status: nullizygosity for the JAK2 46/1 haplotype is associated with inferior survivalA Tefferi, T L Lasho, M M Patnaik, et al.Bone Marrow Transplantation|September 11, 2001
Peri-engraftment respiratory distress syndrome during autologous hematopoietic stem cell transplantationS A Capizzi, S Kumar, N E Huneke, et al.Bone Marrow Transplantation|November 20, 2003
Effect of allogeneic stem cell transplantation on bone marrow angiogenesis in chronic myelogenous leukemiaS Kumar, M R Litzow, S V RajkumarBlood Cancer Journal|April 1, 2017
Prognostic relevance of lymphocytopenia, monocytopenia and lymphocyte-to-monocyte ratio in primary myelodysplastic syndromes: a single center experience in 889 patientsL Saeed, M M Patnaik, K H Begna, et al.Journal of Hematotherapy & Stem Cell Research|March 30, 2000
Optimizing preparation of normal dendritic cells and bcr-abl+ mature dendritic cells derived from immunomagnetically purified CD14+ cellsA B Dietz, P A Bulur, M R Erickson, et al.Blood Reviews|April 25, 2026
Immunotherapy in acute myeloid leukemia: The antibodies, TriKEs, and CARs on the arduous road to cureB Adhikari, M R Litzow, A L DiasLeukemia|April 6, 2013
Personalized management of essential thrombocythemia-application of recent evidence to clinical practiceA Tefferi, T BarbuiBlood Reviews|July 12, 2011
JAK inhibitors in myeloproliferative neoplasms: rationale, current data and perspectiveA Tefferi, A PardananiBritish Journal of Haematology|December 12, 2001
Pruritus in polycythaemia vera: prevalence, laboratory correlates and managementF Diehn, A TefferiBlood Cancer Journal|December 16, 2014
Definition and management of ruxolitinib treatment failure in myelofibrosisA Pardanani, A TefferiPageof 30